Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

The spread of coronavirus disease 2019 (COVID-19) throughout the world has resulted in stressful healthcare burdens and global health crises. Developing an effective measure to protect people from infection is an urgent need. The blockage of interaction between angiotensin-converting enzyme 2 (ACE2)...

Full description

Bibliographic Details
Main Authors: Canhao Wu, Qin Xu, Huiyuan Wang, Bin Tu, Jiaxin Zeng, Pengfei Zhao, Mingjie Shi, Hong Qiu, Yongzhuo Huang
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Acta Pharmaceutica Sinica B
Subjects:
SARS-CoV-2
COVID-19
Spike protein
Pseudovirus
Extracellular vesicles
ACE2
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383521003464

Internet

http://www.sciencedirect.com/science/article/pii/S2211383521003464

Similar Items